Výsledky vyhledávání - "B. U. Mueller"

Autor: B U, Mueller

Publikováno v: Current Opinion in Pediatrics. 9:178-183

Over the last few years, several new antiviral agents have been added to the chemotherapeutic armamentarium. This review discusses advances in the treatment of HIV disease in children and adults. More pronounced antiviral effects have been achieved t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3617c64cd67df49124ff5550e0f5188a
https://doi.org/10.1097/00008480-199704000-00012

Zobrazit plný text záznamu

Pleural tumors as sole primary manifestation of acute promyelocytic leukemia

Autor: M. Solenthaler, E. Oppliger-Leibundgut, E. M. Garamvoelgyi, B. U. Mueller, T. Pabst, A. U. Buerger, Martin F. Fey

Publikováno v: Mueller, B U; Buerger, A U; Solenthaler, M; Garamvoelgyi, E M; Oppliger-Leibundgut, E; Fey, M F; Pabst, T (2006). Pleural tumors as sole primary manifestation of acute promyelocytic leukemia. Annals of oncology, 17(4), pp. 722-3. Oxford: Oxford University Press 10.1093/annonc/mdj062

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a0122195eaeb156f5f462db709bc13c
https://boris.unibe.ch/18997/1/mdj062.pdf

Zobrazit plný text záznamu

Prevention of red cell dehydration: a possible new treatment for sickle cell disease

Autor: B U, Mueller, C, Brugnara

Publikováno v: Pediatric pathologymolecular medicine. 20(1)

One of the pathogenetic mechanisms responsible for sickling of erythrocytes in patients with sickle cell disease is the decreased hydration status of the cells. In this brief review, we discuss the pathophysiologic background and explore some new tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0a84597c1ae277099152bd128d1e842a
https://pubmed.ncbi.nlm.nih.gov/12673842

Zobrazit plný text záznamu

Cancers in children infected with the human immunodeficiency virus

Autor: B U, Mueller

Publikováno v: The oncologist. 4(4)

The AIDS epidemic continues unabated in Africa, Asia, and South America, and since patients survive longer, the number of chronically immunocompromised individuals is increasing in Europe and the United States. The number of children with HIV infecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::40664420e4a2a9e850cac846b9e920b9
https://pubmed.ncbi.nlm.nih.gov/10476542

Zobrazit plný text záznamu

Cytokines and biological response modifiers in the treatment of infection

Autor: B U, Mueller, P A, Pizzo

Publikováno v: Cancer treatment and research. 96

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::850d5cc7336d0e5a479c12688a80d413
https://pubmed.ncbi.nlm.nih.gov/9711401

Zobrazit plný text záznamu

Cancer in children with primary or secondary immunodeficiencies

Autor: B U, Mueller, P A, Pizzo

Publikováno v: The Journal of pediatrics. 126(1)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2036f69ed5c9a7453cfd1f1e23cec4c7
https://pubmed.ncbi.nlm.nih.gov/7503894

Zobrazit plný text záznamu

High failure rate of dapsone and pentamidine as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected children

Autor: S A, Nachman, B U, Mueller, M, Mirochnick, P A, Pizzo

Publikováno v: The Pediatric infectious disease journal. 13(11)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fa7d88d5e720e5dfeea1d0d3149c7b22
https://pubmed.ncbi.nlm.nih.gov/7845719

Zobrazit plný text záznamu

Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infection

Autor: B U, Mueller, K M, Butler, V L, Stocker, F M, Balis, P, Brouwers, P, Jarosinski, R N, Husson, L L, Lewis, D, Venzon, P A, Pizzo

Publikováno v: Pediatrics. 94(5)

Didanosine has demonstrated promising antiviral activity and a tolerable toxicity profile in short term studies. We describe a cohort of HIV-infected children who were treated for a prolonged period of time with didanosine.Children (6 months to 18 ye

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::28324af0883f8571825a61faac99de29
https://pubmed.ncbi.nlm.nih.gov/7936903

Zobrazit plný text záznamu

Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection

Autor: R N, Husson, B U, Mueller, M, Farley, L, Woods, A, Kovacs, J C, Goldsmith, J, Ono, L L, Lewis, F M, Balis, P, Brouwers

Publikováno v: Pediatrics. 93(2)

Zidovudine and didanosine are both beneficial for the treatment of human immunodeficiency virus (HIV) infection in children. Because disease progression and toxicity often limit their long-term use as single agents, new approaches to using nucleoside

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9a7bfa3c7726bd07a83da13afa050913
https://pubmed.ncbi.nlm.nih.gov/7907174

Zobrazit plný text záznamu

Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine

Autor: K M, Butler, D, Venzon, N, Henry, R N, Husson, B U, Mueller, F M, Balis, F, Jacobsen, L L, Lewis, P A, Pizzo

Publikováno v: Pediatrics. 91(4)

To define predictive or contributory risk factors for pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine (ddI), the authors evaluated 95 children, 3 months to 18 years of age, who had received ddI at 60 to 540 mg/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::77177c7371bfbf82bfce7cae3c9ecd1f
https://pubmed.ncbi.nlm.nih.gov/7681940

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání